N-palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice

Chemico-Biological Interactions

Volumn 242, Issue , 2015, Pages 153-162

  Min, A Young ^a   Doo, Choon Nan ^a   Son, Eun Jung ^a   Sung, Nak Yun ^a   Lee, Kun Jong ^a   Sok, Dai Eun ^a   Kim, Mee Ree ^a  

^a Chungnam National University   (South Korea)

Author keywords

Antioxidant system; BDNF; Cholinergic function; p CREB; Pal 5HT; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID; CHOLINE ACETYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; N PALMITOYL SEROTONIN; NAD(P)H QUININE OXIDOREDUCTASE 1; OXIDOREDUCTASE; SUPEROXIDE DISMUTASE; TACRINE; UNCLASSIFIED DRUG; CREB1 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; NQO1 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SCOPOLAMINE BROMIDE; SEROTONIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; CELL LOSS; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME REGULATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; LEARNING DISORDER; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SCOPOLAMINE-INDUCED COGNITIVE DEFECT; STEP-THROUGH PASSIVE AVOIDANCE TEST; ANALOGS AND DERIVATIVES; ANIMAL; AVOIDANCE BEHAVIOR; CHEMICALLY INDUCED; DRUG EFFECTS; HIPPOCAMPUS; INSTITUTE FOR CANCER RESEARCH MOUSE; MAZE TEST; MEMORY DISORDERS; METABOLISM;

ACETYLCHOLINESTERASE; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLINE O-ACETYLTRANSFERASE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE, INBRED ICR; NAD(P)H DEHYDROGENASE (QUINONE); NITRIC OXIDE SYNTHASE TYPE II; SCOPOLAMINE HYDROBROMIDE; SEROTONIN;

EID: 84944050432     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2015.09.016     Document Type: Article

References (57)

1. W.E. Müller, A. Eckert, C. Kurz, G.P. Eckert, and K. Leuner Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects Mol. Neurobiol. 41 2010 159 171
2. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N. Engl. J. Med. 362 2010 329 344
3. A.V. Terry, P.M. Callahan, B. Hall, and S.J. Webster Alzheimer's disease and age-related memory decline (preclinical) Pharmacol. Biochem. Behav. 99 2011 190 210
4. B. Halliwell Oxidative stress and neurodegeneration: where are we known J. Neurochem. 97 2006 1634 1658
5. K. Leuner, T. Schütt, C. Kurz, S.H. Eckert, C. Schiller, A. Occhipinti, S. Mai, M. Jendrach, G.P. Eckert, S.E. Kruse, R.D. Palmiter, U. Brandt, S. Dröse, I. Wittig, M. Willem, C. Haass, A.S. Reichert, and W.E. Müller Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation Antioxid. Redox Signal 16 2012 1421 1433
6. K. Leuner, W.E. Müller, and A.S. Reichert From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease Mol. Neurobiol. 46 2012 186 193
7. H.K. Anandatheerthavarada, and L. Devi Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease Neuroscientist 13 2007 626 638
8. P.F. Pavlov, C.H. Petersen, E. Glaser, and M. Ankarcrona Mitochondrial accumulation of APP and Abeta: significance for Alzheimer disease pathogenesis J. Cell Mol. Med. 3 2009 4137 4145
9. J.B. Melo, P. Agostinho, and C.R. Oliveira Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide Neurosci. Res. 45 2003 117 127
10. T. Ahmed, and A.H. Gilani Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease Pharmacol. Biochem. Behav. 91 2009 554 559
11. M.J. Calkins, D.A. Johnson, J.A. Townsend, M.R. Vargas, J.A. Dowell, T.P. Williamson, A.D. Kraft, J.-M. Lee, J. Li, and J.A. Johnson The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease Antioxid. Redox Signal 11 2009 497 508
12. M. Sandberg, J. Patil, B. D'Angelo, S.G. Weber, and C. Mallard NRF2-regulation in brain health and disease: Implication of cerebral Inflammation Neuropharmacol 79 2014 298 306
13. J.A. Araujo, C.M. Studzinski, and N.W. Milgram Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 411 422
14. F. Fadda, S. Cocco, and R. Stancampiano Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats Neuroreport 11 2000 2265 2269
15. M.E. Hasselmo The role of acetylcholine in learning and memory Curr. Opin. Neurobiol. 16 2006 710 715
16. K. Yamada, and T. Nabeshima Brain-derived neurotrophic factor/TrkB signaling in memoryprocesses J. Pharmacol. Sci. 91 2003 267 270
17. P. Bekinschtein, M. Cammarota, I. Izquierdo, and J.H. Medina Reviews: BDNF and memory formation and storage Neuroscientist 14 2008 147 156
18. Z. Shi, L. Chen, S. Li, S. Chen, X. Sun, L. Sun, Y. Li, J. Zeng, Y. He, and X. Liu Chronic scopolamine-injection-induced cognitive deficit on reward-directed instrumental learning in rat is associated with CREB signaling activity in the cerebral cortex and dorsal hippocampus Psychopharmacol. Berl. 203 2013 245 260
19. S.W. Hong, J.H. Yang, E.H. Joh, H.J. Kim, and D.H. Kim Gypenoside TN-2 ameliorates scopolamine-induced learning deficit in mice J. Ethnopharmacol. 134 2011 1010 1013
20. R. Pandey, K. Mousawy, M. Nagarkatti, and P. Nagarkatti Endocannabinoids and immune regulation Pharmacol. Res. 60 2009 85 92
21. J.M. Yoo, D.E. Sok, and M.R. Kim Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells Int. Immunopharmacol. 17 2013 123 131
22. H. Li, J.T. Wood, K.M. Whitten, S.K. Vadivel, S. Seng, A. Makriyannis, and H.K. Avraham Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells Br. J. Pharmacol. 170 2013 489 505
23. J.M. Yoo, E.S. Park, M.R. Kim, and D.E. Sok Inhibitory effect of N-Acyl dopamines on IgE-mediated allergic response in RBL-2H3 cells Lipids 48 2013 383 393
24. M.C. Jin, J.M. Yoo, D.E. Sok, and M.R. Kim Neuroprotective effect of N-acyl 5-hydroxytryptamines on glutamate-induced cytotoxicity in HT-22 cells Neurochem. Res. 39 2014 2440 2451
25. J. Du, M. Ma, Q. Zhao, L. Fang, J. Chang, Y. Wang, R. Fei, and X. Song Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia Neuroscience 231 2013 345 352
26. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colormetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
27. W.T. Bidlack, and A.L. Tappel Damage to microsomal membrane by lipid peroxidation Lipids 8 1973 177 182
28. M.C. Pinto, A.M. Mata, and J. Lopes-Barea Reversible inactivation of Sacchromyces cerevasiae glutathione reductase under reducing conditions Arch. Biochem. Biophys. 228 1984 1 12
29. A.L. Tappel, S. Fleischer, and L. Packer Glutathione peroxidase Methods Enzymol. 52 1978 506 523
30. J.C. McCord, and I. Fridovich Superoxide dismutase. An enzymatic function for erythrocuprein J. Biol. Chem. 244 1969 6049 6055
31. D.E. Sok, S.H. Oh, Y.B. Kim, H.G. Kang, and M.R. Kim Neuroprotection by extract of Petasites japonicus leaves, a traditional vegetable, against oxidative stress in brain of mice challenged with kainic acid Eur. J. Nutr. 45 2006 61 69
32. M.C. Polidori, and G. Nelles Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives Curr. Pharm. Res. 20 2014 3083 3092
33. G.A. Farías, L. Guzmán-Martínez, C. Delgado, and R.B. Maccioni Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders J. Alzheimers Dis. 42 2014 357 367
34. S. Schaffer, H. Asseburg, S. Kuntz, W.E. Muller, and G.P. Eckert Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria Mol. Neurobiol. 46 2012 161 178
35. D.J. Selkoe Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases Nat. Cell Biol. 6 2004 1054 1061
36. E. Rangel-López, A.L. Colín-González, A.L. Paz-Loyola, E. Pinzón, I. Torres, I.N. Serratos, P. Castellanos, M. Wajner, D.O. Souza, and A. Santamaría Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain Neuroscience 285 2015 97 106
37. R.T. Bartus, R.L. Dean 3rd, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
38. R. Morris Developments of a water-maze procedure for studying spatial learning in the rat J. Neurosci. Methods 11 1984 47 60
39. A. Blokand, E. Geraerts, and A. Been A detailed analysis of rat's spatial memory in a probe trial of a Morris task Behav. Brain Res. 154 2004 71 75
40. C.A. Lorenzini, E. Baldi, C. Bucherelli, B. Sacchett, and G. Tassoni Role of dorsal hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response: a tetrodotoxin functional inactivation study Brain Res. 730 1996 32 39
41. P.T. Francis, A.M. Palmer, M. Snape, and G.K. Wilcock The cholinergic hypothesis of Alzheimer's disease: a review of progress J. Neurol. Neurosurg. Psychiatry 66 1999 137 147
42. C.G. Ballard, N.H. Greig, A.L. Guillozet-Bongaarts, A. Enz, and S. Darvesh Cholinesterases: roles in the brain during health and disease Curr. Alzheimer Res. 2 2005 307 318
43. Q. Chang, and P.E. Gold Switching memory systems during learning: changes in patterns of brain acetylcholine release in the hippocampus and striatum in rats J. Neurosci. 23 2003 3001 3005
44. D.A. El-Sherbiny, A.E. Khalifa, A.S. Attia, and E.E.S. Eldenshary Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine Pharmacol. Biochem. Behav. 76 2003 523 533
45. S.H. Kwon, S.X. Ma, H.J. Joo, S.Y. Lee, and C.G. Jang Inhibitory Effects of Eucommia ulmoides Oliv. Bark on Scopolamine-Induced Learning and Memory Deficits in Mice Biomol. Ther. Seoul. 21 2013 462 469
46. H. Kumar, B.W. Kim, S.Y. Song, J.S. Kim, I.S. Kim, Y.S. Kwon, S. Koppula, and D.K. Choi Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms Biosci. Biotechnol. Biochem. 76 2012 1518 1522
47. J.C.S. Breitner The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease Ann. Rev. Med. 47 1996 401 411
48. E.G. McGeer, and P.L. McGeer Brain inflammation and the therapeutic implications Curr. Pharm. Des. 5 1999 821 836
49. U. Andersson, and K.J. Tracey Reflexes in inflammation and immunity J. Exp. Med. 209 2012 1057 1068
50. I. Shaked, A. Meerson, Y. Wolf, R. Avni, D. Greenberg, A. Gilboa-Geffen, and H. Soreq MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase Immunity 31 2009 965 973
51. S. Shenhar-Tsarfaty, S. Berliner, N.M. Bornstein, and H. Soreq Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease J. Mol. Neurosci. 53 2014 298 305
52. A. Soreq Checks and balances on cholinergic signaling in brain and body function Trends Neurosci. 38 2015 448 458
53. J.C. Madara, and E.S. Levine Presynaptic and postsynaptic NMDA receptors mediate distinct effects of BDNF on synaptic transmission J. Neurophysiol. 100 2008 3175 3184
54. M. Mizuno, K. Yamada, N. Maekawa, K. Saito, M. Seishima, and T. Nabeshima CREB phosphorylation as a molecular marker of memory processing in the hippocampus for spatial learning Behav. Brain Res. 133 2002 135 141
55. B. Bozon, A. Kelly, S.A. Josselyn, A.J. Silva, S. Davis, and S. Laroche MAPK, CREB and zif268 are all required for the consolidation of recognition memory philosophical transactions of the Royal Society B Biol. Sci. 358 2003 805 814
56. E.H. Joh, I.A. Lee, and D.H. Kim Kalopanaxsaponins A and B isolated from Kalopanax pictus ameliorate memory deficits in mice Phytother. Res. 26 2012 546 551
57. M. Alonso, M.R.M. Vianna, I. Izquierdo, and J.H. Medina Signaling mechanisms mediating BDNF modulation of memory formation in vivo in the hippocampus Cell Mol. Neurobiol. 22 2002 647 658